This structure creates a perivascular space that facilitates drainage of cerebrospinal fluid (CSF) for immunosurveillance (25)
[1] [5] Currently available GLP-1 medications in the United States include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), exenatide (Byetta, Bydureon), and tirzepatide (Mounjaro, Zepbound)though tirzepatide is technically a dual GLP-1/GIP receptor agonist
Call Your Provider If You Experience: Persistent vomiting
Glucagon-like peptide-1 receptor agonists as insulin add-on therapy in patients with inadequate glycemic control in type 2 diabetes mellitus: lixisenatide as a new therapeutic option
For best results, continuous use for at least three months is often recommended.